{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:34Z","timestamp":1791357274315,"version":"4.3.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Case Reports"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/j.ebcr.2014.08.001","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T07:15:54Z","timestamp":1410851754000},"page":"152-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["A case of rhabdomyolysis in which levetiracetam was suspected as the cause"],"prefix":"10.1016","volume":"2","author":[{"given":"Hisanao","family":"Akiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiteru","family":"Haga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoshi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebcr.2014.08.001_bb0005","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0010","series-title":"Otsuka Pharmaceutical Co., Ltd. VIII. Safety information. Interview form; E Keppra\u00ae tablets 250mg\u00b7500mg & E Keppra\u00ae dry syrup 50%","first-page":"45","author":"Drug Information Center","year":"2013"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mus.10053","article-title":"Rhabdomyolysis: a review","volume":"25","author":"Warren","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0025","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0960-8966(01)00228-0","article-title":"Valproic acid triggers acute rhabdomyolysis in a patient with carnitine palmitoyltransferase type II deficiency","volume":"11","author":"Kottlors","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0030","series-title":"Dainippon Sumitomo Pharmaceutical Co., Ltd. VIII. Safety information. Interview form; EXCEGRAN\u00ae tablets 100mg & EXCEGRAN\u00ae powder 20%","first-page":"19","author":"Product Information Center","year":"2014"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0035","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5414\/CPP43436","article-title":"Unsuspected rhabdomyolysis associated with phenytoin","volume":"43","author":"Santos-Calle","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-1211(03)00080-9","article-title":"The KEEPER\u21221 trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study","volume":"54","author":"Morrell","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.eplepsyres.2007.06.002","article-title":"The SKATE\u2122 study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy","volume":"76","author":"Steinhoff","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yebeh.2010.03.016","article-title":"Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: the Asia SKATE II study","volume":"18","author":"Kwan","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0055","first-page":"38","article-title":"Effect of levetiracetam on truncal tic in neuroacanthocytosis","volume":"15","author":"Lin","year":"2006","journal-title":"Acta Neurol Taiwan"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2377-12-97","article-title":"Probable levetiracetam-related serum alkaline phosphatase elevation","volume":"12","author":"Xiong","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0065","series-title":"Otsuka Pharmaceutical Co., Ltd. VII. Pharmacokinetics. Interview form; E Keppra\u00ae tablets 250mg\u00b7500mg & E Keppra\u00ae dry syrup 50%","first-page":"33","author":"Drug Information Center","year":"2013"},{"key":"10.1016\/j.ebcr.2014.08.001_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1345\/aph.1E285","article-title":"Acute rhabdomyolysis associated with ofloxacin\/levofloxacin therapy","volume":"39","author":"Hsiao","year":"2005","journal-title":"Ann Pharmacother"}],"container-title":["Epilepsy & Behavior Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221332321400036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221332321400036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:54:06Z","timestamp":1761980046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221332321400036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":14,"alternative-id":["S221332321400036X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebcr.2014.08.001","relation":{},"ISSN":["2213-3232"],"issn-type":[{"value":"2213-3232","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of rhabdomyolysis in which levetiracetam was suspected as the cause","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebcr.2014.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}